復星旅文(01992.HK)簽約三亞復遊城項目
復星旅文(01992.HK)宣布,旗下上海復星旅遊管理與三亞市人民政府簽訂合作協議,將在三亞市設立全資子公司,以投資開發三亞復遊城項目。
公司表示,此前復星旅管開發建設「三亞亞特蘭蒂斯」項目,累計接待遊客近900萬人次,其中境外遊客超45萬人次,累計納稅23.8億元人民幣,今次再度與三亞簽約,料將進一步促進三亞旅遊產業升級。
海南自由貿易港2021年重點項目集中籤約儀式於6月19日在海口舉行,其中三亞共有9個項目參加此次集中簽約,總投資額約281億元人民幣,預計引入外資3.15億美元,項目涵蓋旅遊業、現代服務業和高新技術產業等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.